Drugs Made In America Acquisition Corp.
DMAA- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002028614
No open-market purchases or sales by Drugs Made In America Acquisition Corp. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $124.9M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Drugs Made In America Acquisition Corp. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 39 | 23 | −16 |
| Shares | 22.9M | 12.0M | −10.9M (−47.7%) |
| Value | $237.3M | $124.9M | −$112.5M (−47.4%) |
New holders (1)
Institutions that held Drugs Made In America Acquisition Corp. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Logan Stone Capital, LLC | 109,959 | $1.17M | 0.25% |
Sold out (17)
Institutions that held Drugs Made In America Acquisition Corp. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| D. E. Shaw & Co., Inc. | 690,000 | $7.25M |
| Shaolin Capital Management LLC | 550,000 | $5.76M |
| Radcliffe Capital Management, L.P. | 546,808 | $5.74M |
| LMR Partners LLP | 500,000 | $5.24M |
| Rivernorth Capital Management, LLC | 417,998 | $4.38M |
| Whitebox Advisors LLC | 400,000 | $4.19M |
| CNH Partners LLC | 357,585 | $3.75M |
| Hudson Bay Capital Management LP | 297,833 | $3.13M |
| Context Capital Management, LLC | 250,000 | $2.62M |
| Governors Lane LP | 250,000 | $2.62M |
| L1 Global Manager Pty Ltd | 200,000 | $2.10M |
| Goldman Sachs Group Inc | 119,686 | $1.25M |
| DLD Asset Management, LP | 100,559 | $1.05M |
| Warberg Asset Management LLC | 92,054 | $966.1K |
| Periscope Capital Inc. | 50,000 | $524.8K |
| BNP Paribas Arbitrage, SA | 14,737 | $154.4K |
| Citadel Advisors LLC | 10,476 | $110.0K |